Clinical Trials
Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide
Primary Endpoint Met in Study of Postmenopausal Women With Osteoporosis Transitioning From Bisphosphonate Treatment Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels:...
Clinical Trials
Immunotherapy Atezolizumab Shrank Tumors in People with a Specific Type of Lung Cancer
Genentech will discuss results with the U.S. Food and Drug Administration (FDA) as part of atezolizumab’s Breakthrough Therapy Designation in lung cancer ...
Clinical Trials
AstraZeneca establishes Scientific Review Board to support clinical trial data transparency commitment
AstraZeneca today announced the creation of a Scientific Review Board that will act independently to assess requests from external researchers which include patient level...
Clinical Trials
UCB clinical trials policy
UCB is committed to providing the opportunity to patients to make informed decisions about participating in clinical trials. UCB is committed...
Clinical Trials
clinical trials are critical for determining the safety and efficacy of new medicines and are integral to Roche’s strategy of developing innovative medicines and...
Roche is committed to sharing data from clinical trials and has registered and posted summary reports for trials involving patients on clinicaltrials.gov and on...
Clinical Trials
Disclosure Policy of the Astellas Group for Information on Conduct and Results of Clinical Trials.
The Astellas Group (*1) (hereinafter collectively “Astellas”) recognises that making clinical trial information and results more widely available to researchers, healthcare professionals, patients, and...
News
New study investigating the effect of low-molecular-weight heparins on the treatment of blood clots in cancer patients
The largest completed study to date on treatments to reduce recurrence of blood clots in cancer patients, sponsored by LEO Pharma, has now been...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read